About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Phoenix | 99 Studies

Clinical Trials EpilepsyPhoenix

Epilepsy Clinical Trials in Phoenix

Find 99 clinical trials for epilepsy near Phoenix, Arizona. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 99 trials

CompletedDetermine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresThe purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsyNCT00522275·Birmingham, Alabama and 59 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedRetigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in EpilepsyThis Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 1200 mg/day, in three equally divided doses, compared with placebo in patients…NCT00232596·Birmingham, Alabama and 53 others

RecruitingAn Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic SeizuresAn Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic SeizuresNCT06908356·Phoenix, Arizona and 10 others

CompletedSafety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset SeizuresThe purpose of the trial is to evaluate the safety of intravenous (iv) lacosamide delivered in a single dose followed by 6.5 days of oral lacosamide treatment in subjects with…NCT00655551·Phoenix, Arizona and 6 others

CompletedTrial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset SeizuresThe objective of this historical-controlled trial is to demonstrate the efficacy and safety of conversion to Lacosamide monotherapy in subjects with Partial-onset Seizures who are…NCT00520741·Alabaster, Alabama and 157 others

CompletedClobazam in Patients With Lennox-Gastaut SyndromeThe purpose of this study is to evaluate the safety and efficacy of clobazam as adjunctive therapy in the treatment of seizures which lead to drop attacks (drop seizures) in…NCT00518713·Huntsville, Alabama and 52 others

CompletedRandomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC SeizuresThis trial is intended to study the safety and effectiveness of an new anti-epileptic drug (AED) on Primary Generalized Tonic-Clonic (PGTC) Seizures.NCT03678753·Phoenix, Arizona and 115 others

CompletedRNS System NAUTILUS StudyTo demonstrate that the RNS System for thalamic stimulation is safe and effective as an adjunctive therapy for the reduction of primary generalized seizures in individuals 12…NCT05147571·Birmingham, Alabama and 22 others

Enrolling by invitationLong-term Safety and Tolerability of BHV-7000A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsyNCT06443463·Birmingham, Alabama and 282 others

TerminatedStudy to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure ClustersThe purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.NCT01390220·Phoenix, Arizona and 89 others

CompletedStudy to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMUThis study is designed to evaluate the efficacy, safety, and tolerability of USL261 compared with that of intranasal (IN) placebo for the treatment of intermittent bouts of…NCT01999777·Phoenix, Arizona and 50 others

TerminatedA Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresAntiepileptic drugs (AEDs) are the main treatment for epilepsy; however, only a limited number of AEDs are approved for use as monotherapy.NCT00698581·Phoenix, Arizona and 52 others

CompletedPhase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label ExtensionThe study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3…NCT01963208·Birmingham, Alabama and 70 others

CompletedBrivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresThis study will evaluate the efficacy and safety of brivaracetam at doses of 100 and 200mg/day compared to placebo as adjunctive treatment in adult focal epilepsy subjects with…NCT01261325·Phoenix, Arizona and 206 others

CompletedOpen-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset SeizuresThe study will evaluate the long-term safety and tolerability of pregabalin in pediatric patients, age 1 month through 16 years, with partial onset seizures.NCT00448916·Mobile, Alabama and 17 others

Active not recruitingSafety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) SeizuresPrimary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizuresNCT05067634·Phoenix, Arizona and 34 others

CompletedConversion to Monotherapy Study With Keppra XR for Partial SeizuresThe primary objective of this study is to assess the efficacy of two doses of Keppra XR compared with a historical control as the placebo, in the monotherapy treatment of partial…NCT00419094·Dothan, Alabama and 44 others

TerminatedStudy to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure ClustersThe purpose of this study is to examine the long-term safety and tolerability of USL261 in the treatment of seizure clusters.NCT01529034·Phoenix, Arizona and 57 others

CompletedA Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset SeizuresA study of a drug to be used in addition with another drug to treat adults with Uncontrolled Partial-onset SeizuresNCT03116828·Mobile, Alabama and 54 others

RecruitingA Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresThis is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as…NCT05667142·Mobile, Alabama and 137 others

PreviousPage 4 of 5Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia